This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Conicet), Fundacion Sales, Inis Biotech LLC. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 82 
1 out of 8 
1 out of 20 
Years Active: 2018
Title: Santiago Di Lella: Innovator in Immuno-Modulating Research
Introduction
Santiago Di Lella is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the development of Galectin-1 polypeptide variants that have potential therapeutic applications.
Latest Patents
Santiago Di Lella holds a patent for GAL-1 variants having immuno-modulating properties and methods of using the same. This patent describes Galectin-1 polypeptide variants that include a mutation of the histidine residue corresponding to position 52 of the full-length amino acid sequence of native human Gal-1. The mutation involves substituting histidine with tyrosine or asparagine, which provides resistance to acidosis that would otherwise deactivate native human Gal-1. Additionally, the variants may include one or more mutations of the cysteine residue at positions 2, 16, or 88, with substitutions to serine, offering resistance to oxidation.
Career Highlights
Throughout his career, Santiago Di Lella has worked with notable organizations, including the National Scientific and Technical Research Council (CONICET) and Inis Biotech LLC. His research has been pivotal in advancing the understanding of immuno-modulation and its applications in medicine.
Collaborations
Santiago has collaborated with esteemed colleagues such as Gabriel Adrián Rabinovich and Dario Ariel Estrin. These partnerships have enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Santiago Di Lella is a distinguished inventor whose work in immuno-modulating research has led to valuable patents and collaborations. His contributions continue to impact the scientific community and pave the way for future innovations in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile